PCOS has a new name: PMOS. What changed, and what did not?

PCOS has a new name: PMOS.

PMOS stands for polyendocrine metabolic ovarian syndrome. The old name, polycystic ovary syndrome, put too much attention on ovarian cysts. The newer name puts the endocrine and metabolic parts closer to the center.

This is a terminology change, not a reason to throw out your diagnosis, your history, or your current care plan. If your clinician still says PCOS, that does not mean they are talking about a different condition.

Why PCOS was renamed PMOS

The problem with the term PCOS is right there in the name.

"Polycystic ovary syndrome" makes the condition sound mainly ovarian. It also makes people think cysts are required. Many people with the condition do not have cysts, and the "cysts" are often small follicles rather than the kind of cyst people imagine.

The Lancet published the new name in 2026 after a global renaming process involving clinicians, researchers, and patient groups. The new term, polyendocrine metabolic ovarian syndrome, is meant to reflect the full body pattern more accurately: endocrine, metabolic, and ovarian.

That matters because many people are dealing with more than irregular periods or fertility concerns. Insulin resistance, weight changes, cravings, acne, hair changes, sleep problems, mood symptoms, and higher long-term risk for conditions such as type 2 diabetes can all be part of the picture.

What changed medically?

For most patients, the immediate answer is: less than the headline makes it sound.

The name changed. The condition did not suddenly become new. Your symptoms did not become invalid under the old name, and a PMOS label does not automatically mean a different treatment.

Current reporting describes a transition period as clinicians, guidelines, health systems, researchers, and patients adopt the new terminology. NICE draft guidance in the UK is already using PMOS language, with final guidance expected later in 2026, according to The Guardian.

So for now, expect both names to exist side by side:

• PCOS, the name most people still search for and recognize
• PMOS, the newer name that better reflects the metabolic and endocrine picture

Why the new name matters for insulin resistance

The new name makes the metabolic part harder to ignore.

That is important because insulin resistance is common in PCOS/PMOS and can shape cravings, hunger, weight changes, energy crashes, and long-term health risk. It can also be missed when testing stops at fasting glucose or A1C.

If your glucose and A1C are normal and your symptoms still fit insulin resistance, it can be worth asking your clinician about fasting insulin and HOMA-IR. Those tests do not diagnose everything on their own. They can add context when glucose-only testing does not match your actual life.

Start here if you want the lab map: insulin resistance tests: glucose, A1C, fasting insulin, HOMA-IR.

What to say at the doctor now

You do not need to correct your doctor every time they say PCOS.

You can use both terms:

"I have PCOS, now also called PMOS, and I want to understand the metabolic part of it. What screening makes sense for insulin resistance, diabetes risk, lipids, liver health, and hormones?"

If your symptoms are being treated as only a weight problem or only a period problem, the new name gives you useful language:

"My concern goes beyond cycles or fertility. I want to understand the endocrine and metabolic side too."

For a fuller appointment script, read what to ask your doctor if you suspect insulin resistance.

Should apps and resources switch from PCOS to PMOS?

Eventually, probably. Right now, the practical answer is to use both.

Most patients still search for PCOS. Many doctors, clinics, labs, and medical records will keep using PCOS for a while. PMOS is the newer term, and adoption will take time.

That is why Resista. will use PCOS/PMOS together during the transition. If you search for PCOS, you should still find the support you need. If you search for PMOS, you should not land in an empty room.

What did not change

The basics still matter:

• bring symptoms alongside your concerns
• ask about insulin resistance when the pattern fits
• do not treat normal A1C as the end of the conversation if symptoms continue
• ask what else should be ruled out
• use medical care for diagnosis and treatment decisions
• build daily routines that you can repeat without turning food into a punishment project

Resista. is not a medical device and does not diagnose or treat PCOS/PMOS. It is a fasting and habit tracker for the daily execution part: fasting windows, protein first, walking after dinner, supplements, evening closer, and craving support.

If you want the app side, start with the PCOS/PMOS app page. If you want the testing side, start with the insulin resistance tests guide.